The Role of PPARγ Gene Polymorphisms, Gut Microbiota in Type 2 Diabetes: Current Progress and Future Prospects.

Authors:
Zhao YK; Zhu XD; Liu R; Yang X; Liang YL and 1 more

Journal:
Diabetes Metab Syndr Obes

Publication Year: 2023

DOI:
10.2147/DMSO.S429825

PMCID:
PMC10638901

PMID:
37954888

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Diabetes Metab Syndr Obes

Abbreviation: Diabetes Metab Syndr Obes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of Serum Uric Acid to High-Density Lipoprotein Cholesterol Ratio with Trunk Fat Mass a…
Wang Y; Xu Y; Hu T and 5 more (2024) - Transparency Score: 3/6
A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region Countries.
Arshad MS; Alqahtani F; Rasool MF. (2024) - Transparency Score: 4/6
Claudin-2 Mediates the Proximal Tubular Epithelial Cell-Fibroblast Crosstalk via Paracrine CTGF.
Guo C; Jiao M; Cui Y and 4 more (2024) - Transparency Score: 3/6
Clinical Evidence of the Relationship Between Alanine Aminotransferase and Diabetic Kidney Disease.
Bi Y; Yang Y; Yuan X and 4 more (2024) - Transparency Score: 3/6
Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM.
Wang X; Liu X; Zhao J and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure All of the authors had no any personal, financial, commercial, or academic conflicts of interest separately."

Evidence found in paper:

"Research on clinical application basic and transformation development of Shenqitangluo Pill in the treatment of type 2 diabetes based on quantity-effect relationship (2022BEG02034) and research on clinical application and transformation development of Dahuangtangluo Pill in the treatment of type 2 diabetes based on quantity-effect relationship (2021CYZC-03)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025